X-67546514-TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC-TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000044.6(AR):c.1418_1420dup(p.Gly473dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 541,667 control chromosomes in the GnomAD database, including 8,015 homozygotes. There are 15,605 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G456G) has been classified as Likely benign.
Frequency
Consequence
NM_000044.6 inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AR | NM_000044.6 | c.1418_1420dup | p.Gly473dup | inframe_insertion | 1/8 | ENST00000374690.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AR | ENST00000374690.9 | c.1418_1420dup | p.Gly473dup | inframe_insertion | 1/8 | 1 | NM_000044.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.262 AC: 21722AN: 82953Hom.: 2882 Cov.: 0 AF XY: 0.173 AC XY: 2876AN XY: 16603
GnomAD4 exome AF: 0.178 AC: 81685AN: 458710Hom.: 5134 Cov.: 25 AF XY: 0.119 AC XY: 12728AN XY: 106688
GnomAD4 genome AF: 0.262 AC: 21718AN: 82957Hom.: 2881 Cov.: 0 AF XY: 0.173 AC XY: 2877AN XY: 16613
ClinVar
Submissions by phenotype
Partial androgen insensitivity syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | May 04, 2023 | African/African American population allele frequency is 24.38% (rs760580125, 767/2,962 alleles, 117 homozygotes, 127 hemizygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.3.2, this variant is classified as BENIGN. Following criteria are met: BA1 - |
Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 13, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at